Exact Imaging offers the ExactVu micro‑ultrasound platform, a 29 MHz high‑resolution imaging system that lets urologists visualize and differentiate suspicious prostate tissue in real time.
Funding
$4.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Prostate cancer diagnosis often relies on systematic biopsies that miss clinically significant lesions, while MRI‑targeted biopsies require separate imaging equipment and workflow steps, leading to longer procedures and limited access.
Solution
Exact Imaging’s ExactVu platform delivers real‑time, high‑resolution 29 MHz micro‑ultrasound imaging that can be used alongside conventional transducers within a standard urology workflow. The system enables urologists to visualize and differentiate suspicious prostate regions during the same patient visit, allowing both targeted and systematic biopsies without the need for separate MRI scans. Integrated with the evidence‑based PRI‑MUS protocol, ExactVu guides precise needle placement, improving diagnostic accuracy and reducing the number of procedures required. The platform is FDA‑cleared, CE‑marked, and Health Canada‑licensed, supporting adoption in major markets.
Target Audience
Primary customers are urologists and prostate cancer diagnostic centers seeking to improve biopsy accuracy and efficiency within their existing clinical workflow.
Features
- 29 MHz micro‑ultrasound transducer providing the highest resolution imaging for prostate tissue
- Dual‑mode capability with conventional transducers for abdominal, testicular, and large‑prostate imaging
- Real‑time visualization and targeting of lesions, enabling single‑visit targeted and systematic biopsies
- Integration of the PRI‑MUS evidence‑based protocol to standardize lesion identification and sampling
- Compatibility with existing urological equipment and workflow, requiring no additional imaging suite
- FDA 510(k) clearance, CE Mark, and Health Canada license for regulatory compliance